Difference between revisions of "Steroid Agents"
(7 intermediate revisions by 3 users not shown) | |||
Line 1: | Line 1: | ||
− | == | + | {{unfinished}} |
− | The only available steroid anaesthetic for use in veterinary patients is '''alfaxalone''' | + | {{toplink |
+ | |linkpage =Anaesthesia | ||
+ | |linktext =Anaesthesia | ||
+ | |maplink= Anaesthesia Content Map - WikiClinical | ||
+ | |sublink1=Anaesthetic Drugs | ||
+ | |subtext1=Anaesthetic Drugs | ||
+ | |sublink2=Injectable Agents | ||
+ | |subtext2=Injectable Agents | ||
+ | |pagetype=Clinical | ||
+ | }} | ||
+ | <br> | ||
+ | |||
+ | The only available steroid anaesthetic for use in veterinary patients is '''alfaxalone'''. It is a progesterone derived ''neurosteroid''. | ||
==Mechanism of Action== | ==Mechanism of Action== | ||
Line 6: | Line 18: | ||
==Pharmacological Considerations== | ==Pharmacological Considerations== | ||
− | Alfaxalone is | + | Alfaxalone can be administered intravenously and intramuscularly. It is available as either a single agent solution at 10mg/ml, or in combination with alfadolone with polyoxyethylated castor oil as a solvent. It has a rapid onset of action, inducing anaesthesia with 30-60 seconds when given intravenously. Its duration of action is dose dependent. If given intramuscularly, onset of anaesthesia is within 7-10 minutes. However, it has a varying degree of effect and may only sedate the patient. Recovery is dependent on metabolism via glucuronidation processes, rather then redistribution. |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
==Contraindications and Side Effects== | ==Contraindications and Side Effects== | ||
===Cardiovascular Effects=== | ===Cardiovascular Effects=== | ||
− | * | + | *Dose dependent decrease in arterial blood pressure thought to be due to myocardial contractility and stroke volume. |
===Respiratory Effects=== | ===Respiratory Effects=== | ||
− | *Minimal respiratory effects | + | *Minimal respiratory effects. |
===Other Effects=== | ===Other Effects=== | ||
− | * | + | *Histamine release leading to swollen paws and face of dogs that have received agents in polyoxyethylated castor oil. This also makes it contraindicated in cats with asthma or mast cell tumours. |
− | |||
− | |||
==Uses== | ==Uses== | ||
− | Alfaxalone can be used for induction | + | Alfaxalone can be used for induction of anaesthesia in dogs and cats. |
− | |||
− | |||
− | |||
− | |||
− |
Revision as of 15:03, 1 September 2009
This article is still under construction. |
|
The only available steroid anaesthetic for use in veterinary patients is alfaxalone. It is a progesterone derived neurosteroid.
Mechanism of Action
Neurosteroids act similarly to other anaesthetic agents by acting at the GABAa receptor chloride channels to enhance the inhibitory effect of GABA. This produces hypnosis and muscle relaxation.
Pharmacological Considerations
Alfaxalone can be administered intravenously and intramuscularly. It is available as either a single agent solution at 10mg/ml, or in combination with alfadolone with polyoxyethylated castor oil as a solvent. It has a rapid onset of action, inducing anaesthesia with 30-60 seconds when given intravenously. Its duration of action is dose dependent. If given intramuscularly, onset of anaesthesia is within 7-10 minutes. However, it has a varying degree of effect and may only sedate the patient. Recovery is dependent on metabolism via glucuronidation processes, rather then redistribution.
Contraindications and Side Effects
Cardiovascular Effects
- Dose dependent decrease in arterial blood pressure thought to be due to myocardial contractility and stroke volume.
Respiratory Effects
- Minimal respiratory effects.
Other Effects
- Histamine release leading to swollen paws and face of dogs that have received agents in polyoxyethylated castor oil. This also makes it contraindicated in cats with asthma or mast cell tumours.
Uses
Alfaxalone can be used for induction of anaesthesia in dogs and cats.